临床药师参与1例多发性骨髓瘤患者合并带状疱疹治疗的病例分析  

Participation of clinical pharmacists in the drug treatment of one case of multiple myeloma complicated with herpeszoster

作　　者：宋向明 陆敏秋[1] 张威[1] 鲍立[1] 

机构地区：[1]北京积水潭医院药剂科,北京100035 [2]湖州市中心医院临床药学科,浙江湖州313000

出　　处：《临床药物治疗杂志》2017年第10期63-66,共4页Clinical Medication Journal

摘　　要：目的:探讨临床药师在多发性骨髓瘤合并带状疱疹治疗中的作用。方法:临床药师积极参与1例多发性骨髓瘤患者使用硼替佐米致带状疱疹的抗病毒治疗,对带状疱疹药物选择、肾功能不全时剂量调整、药学监护点和用药教育进行分析总结,评估治疗效果。结果:在医师与临床药师协作下,患者带状疱疹好转出院。结论:临床药师参与临床治疗,可以从药物角度为临床医师提供治疗参考,降低了用药风险,提高了患者的满意度。Objective： To explore the role of clinical pharmacists in the treatment of multiple myeloma complicated with herpeszoster. Methods： The clinical pharmacist actively participated in the treatment of herpes zoster induced by bortezomib in one patient with multiple myeloma. The drug choice, dose adjustment for renal insufficiency and key points of pharmaceutical service were analyzed. Results： The physicians adopted the suggestions of the clinical pharmacist. The patient got better and was discharged. Conclusion： The involvement of pharmacists in the clinical practice can provide reference for clinicians and improve the curative effect, safety of drug treatment and patient satisfaction.

关 键 词：多发性骨髓瘤 带状疱疹 阿昔洛韦 药学监护 

分 类 号：R969.3[医药卫生—药理学]